Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD" Results 121 - 140 of 257
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 May 2015, 10:39 am
 The parties have been back in court to fight over other patents, resulting in the decision Synthon B.V. v Teva Pharmaceutical Industries Ltd [2015] EWHC 1395 (Pat), which came out this morning.The patents concerned are EP (UK) 2 177 528 and EP (UK) 2 361 924, both divisionals of EP (UK) 1 799 703, which was revoked by the EPO in opposition proceedings pursuant to Teva's withdrawal of it after a negative preliminary opinion. [read post]
1 Dec 2015, 6:20 am
”) to ward off an unsolicited takeover bid by the Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. [read post]
2 Jan 2008, 9:05 pm
Lupin Limited et al Teva Pharmaceutical Industries Ltd. et al v Hetero Drugs Ltd. [read post]
1 Jun 2012, 1:58 pm by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®ShareTweetTeva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
28 Mar 2014, 5:33 pm
   Procedural History"Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt… [read post]
1 Jul 2008, 6:46 pm
Teva Pharmaceutical Industries received Indian Patent No. 210420 for novel hydrate forms of alendronate sodium having water content of 1.35% to 11.7%. [read post]
8 Nov 2016, 11:53 pm by Kevin LaCroix
  Next, on November 6, 2016, plaintiffs’ lawyers’ filed a securities class action lawsuit in the Central District of California against Teva Pharmaceuticals Industries Ltd. [read post]
15 Aug 2011, 9:55 am by Patrick G. Lee
Teva Pharmaceutical Industries Ltd., which has proposed a generic version of Viagra, argued that the patent was invalid because anyone well-versed in the art of drug making could have gleaned, from prior research, that sildenafil could be effective as an ED treatment. [read post]
11 Dec 2008, 10:30 pm
In response, the plaintiffs, Eli Lilly and Company and Lilly Industries Ltd. [read post]
28 Dec 2007, 1:00 am
International Trade Commission and Flexsys America: CAFC instructs the ITC on claim construction: (IPBiz), (Patent Prospector), (more from IPBiz)Anonymised net drug sales might yet infringe - Eli Lilly & Company and Lilly Icos LLC v 8PM Chemists Ltd: (IPKat),Open source for cost effective drug discovery: (Spicy IP),Challenges to ethical and generic drug producers: (Profitability through simplicity),US: multiple courts - same patent:… [read post]
23 Sep 2008, 9:34 pm
FDA To Collaborate With Complaining Patients On Study Of Reported Problems With This Generic Version Of Antidepressant Wellbutrin XL (Posted by Tom Lamb at By means of a September 23, 2008 Wall Street Journal (WSJ) article, "Wellbutrin Generic to Get New Review", we learned that the FDA is going to re-visit the issues of whether Budeprion XL -- which is made by Impax Laboratories Inc. and distributed by Teva Pharmaceutical Industries… [read post]
27 Jul 2011, 4:06 pm by Lawrence B. Ebert
Caraco :Defendants-Appellees Caraco Pharmaceutical Labora- tories, Ltd. and Sun Pharmaceutical Industries, Ltd. [read post]
3 Nov 2011, 9:55 am by Aaron Barkoff
  Subsequently, LEO Pharma sought to amend its complaint to, among other things, add Teva Pharmaceutical Industries Ltd. as a defendant. [read post]
25 May 2015, 4:15 am
  The parties have been back in court to fight over other patents, resulting in the decision Synthon B.V. v Teva Pharmaceutical Industries Ltd [2015] EWHC 1395 (Pat), which came out last week and which Darren reports in timely fashion.* When functionality cuts deep, it can be hard to handle: Yoshida appeal dismissedValentina's back again to pen on General Court's decision in Joined Cases C‑337/12 P to… [read post]
16 Oct 2007, 2:19 am
Court of Appeal (Civil Division) Austin & Anor v Commissioner of Police of the Metropolis [2007] EWCA Civ 989 (15 October 2007) L’Oreal SA & Ors v Bellure NV & Ors [2007] EWCA Civ 968 (10 October 2007) Holmes-Moorhouse v London Borough of Richmond-Upon-Thames [2007] EWCA Civ 970 (10 October 2007) Procter & Gamble Company v Reckitt Benckiser (UK) Ltd [2007] EWCA Civ 936 (10 October 2007) Charman v Orion Group Publishing Group Ltd… [read post]
28 Nov 2008, 12:49 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: []   Highlights this week included: EPO Enlarged Board of Appeal turns down Wisconsin Alumni Research Foundation (WARF) stem cell application (IAM) (IPKat) (EPO) European Commission releases… [read post]
30 Nov 2020, 6:31 am by Deb Givens
  The European Commission has fined pharmaceutical company Teva and its now subsidiary Cephalon 60.5 million euros for agreeing to delay a cheaper generic version of Cephalon’s sleep disorder medicine. [read post]
30 Apr 2021, 8:07 am by Dan Bressler
The department has taken issue with the firm’s prior representation of fellow defendant Teva Pharmaceutical Industries Ltd. in the criminal probe and its continued representation of both companies in parallel civil litigation. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page:   Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango)   General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors… [read post]